Home›Stock Screener›Dhampur Bio Organics›Financial Statements

Dhampur Bio Organics Complete Financial Statements

6 Years of Data
2026 - 2021

In FY2026, Dhampur Bio Organics (DBOL) reported revenue ₹475 Cr, net profit ₹46 Cr and EPS ₹7.01, with a net profit margin of 9.7% and ROE of 4.5%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse DBOL promoter holding to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 9.68% 2026 data
EBITDA Margin 20.00% 2026 data
Operating Margin 17.00% 2026 data
Return on Assets 1.98% 2026 data
Return on Equity 4.48% 2026 data

Balance Sheet Ratios

Current Ratio 4.17 2026 data
Equity Ratio 44.23% 2026 data
Asset Turnover 0.20 2026 data

DBOL Revenue, Net Profit & EBITDA — Year-on-Year Growth

DBOL YoY (Mar 2025 vs Mar 2026) — revenue +2.2%, net profit +2.2%, EBITDA -2.1%, expenses +3.0%. Examine DBOL quarterly trends for recent quarterly revenue, profit and EPS trends.

Revenue Growth
+2.2%
Year-over-Year
Net Profit Growth
+2.2%
Year-over-Year
EBITDA Growth
-2.1%
Year-over-Year
Expense Growth
+3.0%
Year-over-Year
Assets Growth
-3.2%
Year-over-Year
Equity Growth
+1.5%
Year-over-Year
Operating Cash Flow Growth
+69.2%
Year-over-Year
Investing Cash Flow Growth
+71.2%
Year-over-Year
Financing Cash Flow Growth
-1042.1%
Year-over-Year

DBOL Income Statement — Revenue, EBITDA & Net Profit

Dhampur Bio Organics revenue ₹475 Cr, EBITDA ₹95 Cr, net profit ₹46 Cr, EPS ₹7.01 (2026) — net profit margin 9.7%. For live price, earnings ratios and company overview, see Dhampur Bio Organics stock price NSE.

Periods ₹ Crores
Particulars Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Jun 2021 Dec 2021
Revenue 475 585 571 465 494 495 467 468 468 465 539 805 586 296 521 510 498 595 360 353 348
Expenses 380 524 566 369 492 444 476 382 434 450 519 687 543 285 493 404 464 559 347 318 312
EBITDA 95 61 5 97 2 52 -8 86 34 15 20 118 43 11 29 106 34 35 14 35 36
Operating Profit Margin % 17.00% 2.00% -1.00% 21.00% 0.00% 9.00% -2.00% 18.00% 7.00% 3.00% 4.00% 14.00% 7.00% -2.00% 4.00% 20.00% 6.00% 6.00% 3.00% 9.00% 10.00%
Depreciation 13 13 15 16 12 15 11 14 12 15 11 13 11 14 9 10 8 10 6 7 8
Interest 14 16 14 20 19 11 16 18 21 10 9 13 13 6 9 10 14 5 6 11 3
Profit Before Tax 69 32 -23 61 -29 26 -35 54 1 -10 1 92 19 -8 11 86 12 20 2 17 25
Tax 22 -5 -7 16 -7 9 -12 15 1 -3 0 12 6 -2 3 15 3 5 2 3 7
Net Profit 46 37 -16 45 -22 17 -23 39 0 -7 0 80 13 -6 8 71 8 15 0 14 18
Earnings Per Share (₹) 7.01 5.59 -2.41 6.75 -3.31 2.56 -3.52 5.94 0.02 -1.03 0.01 12.08 1.91 -0.85 1.16 10.69 1.24 2.26 -0.05 2.08 2.70

DBOL Balance Sheet — Assets, Liabilities & Shareholders' Equity

DBOL total assets ₹2,322 Cr, total equity ₹1,027 Cr, total liabilities ₹ Cr (2026) — ROE 4.5%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021
ASSETS
Total Assets 2,322 2,398 2,313 2,078 2,000 1,551
Current Assets 1,179 1,229 1,252 1,125 1,222 901
Fixed Assets 1,131 1,076 1,036 909 690 631
Capital Work in Progress 1 79 13 36 78 7
Investments 2 0 0 0 0 0
Other Assets 1,188 1,242 1,263 1,132 1,232 913
LIABILITIES
Total Liabilities
Current Liabilities 283 305 249 230 165 159
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 1,027 1,012 1,012 989 879 775
Share Capital 66 66 66 66 66 66
Reserves & Surplus 960 945 945 922 812 709

DBOL Cash Flow Statement — Operating, Investing & Financing

Dhampur Bio Organics operating cash flow ₹220 Cr, investing ₹-42 Cr, financing ₹-179 Cr, net cash flow ₹0 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities 220 130 -101 368 -247 0
Investing Activities -42 -146 -166 -209 -124 0
Financing Activities -179 19 170 -78 393 0
Net Cash Flow 0 3 -98 81 23 0